Results 101 to 110 of about 5,534 (181)

J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of <i>Pseudomonas</i> Exotoxin A. [PDF]

open access: yesPharmaceuticals (Basel)
Pincus SH   +8 more
europepmc   +1 more source

177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors. [PDF]

open access: yesMol Cancer Ther
Yamaguchi A   +9 more
europepmc   +1 more source

Pembrolizumab combined with disitamab vedotin in human epidermal growth factor receptor 2-positive metastatic colorectal cancer. [PDF]

open access: yesOncologist
Xu X   +12 more
europepmc   +1 more source

Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates. [PDF]

open access: yesCancer Med
Shimada H   +18 more
europepmc   +1 more source

Profiling EGFR, c-MET, and B7H3 co-expression to guide next-generation dual-drug conjugate strategies in colorectal cancer. [PDF]

open access: yesJ Pathol Clin Res
Yang Y   +12 more
europepmc   +1 more source

Real-world patient-reported outcome comparing antibody-drug conjugates and conventional chemotherapy in metastatic breast cancer. [PDF]

open access: yesOncologist
Milani M   +10 more
europepmc   +1 more source

Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]

open access: yesJ Virol
Pincus SH   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy